Back to search

University of British Columbia

Discovery and characterization of novel LIN28 protein inhibitors suppress stemness in neuroendocrine prostate cancer

Abstract

dc:description

The use of next-generation anti-androgens in the treatment of prostate cancer has led to an increase in therapy-induced neuroendocrine prostate cancer (t-NEPC). Recent studies have identified t-NEPC as a highly aggressive subtype of prostate cancer with poor survival rates. Our laboratory has recently demonstrated that the Lin28B, a core embryonic protein that suppresses the maturation process of the micro-RNA let-7, plays a crucial role in transforming adenocarcinoma prostate cancer (AdPC) into t-NEPC. Lin28B is an RNA-binding protein with two critical domains: the cold-shock domain (CSD) and the zinc-knuckle domain (ZKD). By utilizing both of CSD and ZKD domains, Lin28B protein can structurally binds to the microRNA let-7, which has been reported as a tumor suppressor and oncogene in NEPC, and inhibits its biosynthesis. Therefore, we hypothesize that blocking the interaction of CSD or ZKD with let-7 using a small molecule chemical may provide therapeutic opportunities to treat t-NEPC. In this study, we used a computer-aided drug design strategy to target Lin28B ZKD with small molecule inhibitors. We identified several inhibitors that effectively block Lin28B from binding to let-7 miRNA and restore let-7 biogenesis. Furthermore, we demonstrated that these inhibitors suppress the expression of stem-like pluripotency gene networks and neuroendocrine biomarkers. Lin28B inhibitors also reduces the expression of cancer stem cell surface markers such as CD44 and CD133. We also showed that these inhibitors suppress t-NEPC cell proliferation and clonogenic abilities. Overall, our study discovered several promising small molecules inhibitors of Lin28B that could be developed into potential drugs against NEPC.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ho, Chia Hao
Contributors dc:contributor
  • Dong, Xuesen

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/86124

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ho, Chia Hao. Discovery and characterization of novel LIN28 protein inhibitors suppress stemness in neuroendocrine prostate cancer. master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/86124